Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Valentina P. Putilova"'
Autor:
Anastasiya S. Sokolova, Valentina P. Putilova, Olga I. Yarovaya, Anastasiya V. Zybkina, Ekaterina D. Mordvinova, Anna V. Zaykovskaya, Dmitriy N. Shcherbakov, Iana R. Orshanskaya, Ekaterina O. Sinegubova, Iana L. Esaulkova, Sophia S. Borisevich, Nikolay I. Bormotov, Larisa N. Shishkina, Vladimir V. Zarubaev, Oleg V. Pyankov, Rinat A. Maksyutov, Nariman F. Salakhutdinov
Publikováno v:
Molecules, Vol 26, Iss 8, p 2235 (2021)
To date, the ‘one bug-one drug’ approach to antiviral drug development cannot effectively respond to the constant threat posed by an increasing diversity of viruses causing outbreaks of viral infections that turn out to be pathogenic for humans.
Externí odkaz:
https://doaj.org/article/6e47d2f2d1b14359a5cd3999b60f1774
Autor:
Anna V. Zaykovskaya, D. N. Shcherbakov, Valentina P. Putilova, Ekaterina D. Mordvinova, A. S. Sokolova, Ekaterina O. Sinegubova, Nariman F. Salakhutdinov, Iana L. Esaulkova, Larisa N. Shishkina, Oleg V. Pyankov, Sophia S. Borisevich, Anastasiya V. Zybkina, Olga I. Yarovaya, Vladimir V. Zarubaev, N. I. Bormotov, Iana R. Orshanskaya, Rinat A. Maksyutov
Publikováno v:
Molecules
Volume 26
Issue 8
Molecules, Vol 26, Iss 2235, p 2235 (2021)
Volume 26
Issue 8
Molecules, Vol 26, Iss 2235, p 2235 (2021)
To date, the ‘one bug-one drug’ approach to antiviral drug development cannot effectively respond to the constant threat posed by an increasing diversity of viruses causing outbreaks of viral infections that turn out to be pathogenic for humans.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6573610de19bd8bab5104e0110afd26
http://europepmc.org/articles/PMC8070564
http://europepmc.org/articles/PMC8070564
Autor:
Andrey G. Pokrovsky, Artem D. Rogachev, Oleg V. Pyankov, A. S. Sokolova, Valentina P. Putilova, V. V. Fomenko, Rinat A. Maksyutov, Olga I. Yarovaya, Anna V. Zaykovskaya, Nariman F. Salakhutdinov
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 199
The stability of the new antifiloviral agent AS-358, which is a derivative of borneol and 3-(piperidin-1-yl)propanoic acid, was studied in the blood and blood plasma of rats in vitro. It was found that both in the blood and in the plasma stabilized b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e546ff7cd8a51dc388a17103edb7b72
https://pubmed.ncbi.nlm.nih.gov/33862506
https://pubmed.ncbi.nlm.nih.gov/33862506
Autor:
Valentina P. Putilova, Olga I. Yarovaya, Artem D. Rogachev, Nariman F. Salakhutdinov, Anna V. Zaykovskaya
Publikováno v:
Proceedings of 6th International Electronic Conference on Medicinal Chemistry.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0dbfd13bc5787cd421af6f9e614f77f0
https://doi.org/10.3390/ecmc2020-07304
https://doi.org/10.3390/ecmc2020-07304